ProfileGDS5822 / ILMN_2912872
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 97% 97% 97% 97% 97% 97% 95% 96% 97% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 12149.697
GSM1276600PDAC Late Ablation Control 21649.597
GSM1276601PDAC Late Ablation Control 32358.497
GSM1276602PDAC Late Ablation 12086.297
GSM1276603PDAC Late Ablation 21836.897
GSM1276604PDAC Late Ablation 32797.397
GSM1303940PDAC Late Ablation_anti-CTLA4 11288.795
GSM1303941PDAC Late Ablation_anti-CTLA4 21807.996
GSM1303942PDAC Late Ablation_anti-CTLA4 32131.397